{"entity":{"type":"insider","cik":"0001591464","url":"/insider/0001591464","json_url":"/insider/0001591464.json","name":"Schuetz Thomas J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":25,"first":"2015-06-15","last":"2025-05-27","span_basis":"filed_date"},"name_variants":[{"name":"Schuetz Thomas J.","source":"filing","n_filings":25,"first_seen":"2015-06-15","last_seen":"2025-05-27"}],"transactions":[{"id":4371817,"accession":"0001171843-25-003462","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-25-003462","line_url":"/filing/0001171843-25-003462#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.11,"price_display":"2.11","price_state":"stated","total_value":21100.0,"total_display":"21,100.00","total_whole":"21,100","shares_owned_after":6480825.0,"shares_owned_after_display":"6,480,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-27","filed_date":"2025-05-27","scope":"insider"},{"id":8017920,"accession":"0001171843-23-001588","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-23-001588","line_url":"/filing/0001171843-23-001588#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.37,"price_display":"3.37","price_state":"stated","total_value":33700.0,"total_display":"33,700.00","total_whole":"33,700","shares_owned_after":6021873.0,"shares_owned_after_display":"6,021,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-10","filed_date":"2023-03-10","scope":"insider"},{"id":7948256,"accession":"0001171843-23-001175","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-23-001175","line_url":"/filing/0001171843-23-001175#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":3.98,"price_display":"3.98","price_state":"stated","total_value":79600.0,"total_display":"79,600.00","total_whole":"79,600","shares_owned_after":6011873.0,"shares_owned_after_display":"6,011,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-02-27","scope":"insider"},{"id":8541865,"accession":"0001171843-23-000974","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-23-000974","line_url":"/filing/0001171843-23-000974#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":3.86,"price_display":"3.86","price_state":"stated","total_value":77200.0,"total_display":"77,200.00","total_whole":"77,200","shares_owned_after":5991873.0,"shares_owned_after_display":"5,991,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-15","filed_date":"2023-02-15","scope":"insider"},{"id":8182348,"accession":"0001171843-23-000557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-23-000557","line_url":"/filing/0001171843-23-000557#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":4.05,"price_display":"4.05","price_state":"stated","total_value":81000.0,"total_display":"81,000.00","total_whole":"81,000","shares_owned_after":5471873.0,"shares_owned_after_display":"5,471,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-01-31","scope":"insider"},{"id":8034178,"accession":"0001171843-23-000419","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-23-000419","line_url":"/filing/0001171843-23-000419#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":4.19,"price_display":"4.19","price_state":"stated","total_value":83800.0,"total_display":"83,800.00","total_whole":"83,800","shares_owned_after":5451873.0,"shares_owned_after_display":"5,451,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-24","filed_date":"2023-01-24","scope":"insider"},{"id":6563428,"accession":"0001171843-22-006282","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-22-006282","line_url":"/filing/0001171843-22-006282#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.32,"price_display":"2.32","price_state":"stated","total_value":23200.0,"total_display":"23,200.00","total_whole":"23,200","shares_owned_after":5431873.0,"shares_owned_after_display":"5,431,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-28","filed_date":"2022-09-28","scope":"insider"},{"id":6201698,"accession":"0001171843-22-006243","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-22-006243","line_url":"/filing/0001171843-22-006243#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.27,"price_display":"2.27","price_state":"stated","total_value":34050.0,"total_display":"34,050.00","total_whole":"34,050","shares_owned_after":5421873.0,"shares_owned_after_display":"5,421,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-26","filed_date":"2022-09-27","scope":"insider"},{"id":6324882,"accession":"0001171843-22-006005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-22-006005","line_url":"/filing/0001171843-22-006005#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":3.03,"price_display":"3.03","price_state":"stated","total_value":45450.0,"total_display":"45,450.00","total_whole":"45,450","shares_owned_after":5406873.0,"shares_owned_after_display":"5,406,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-07","filed_date":"2022-09-08","scope":"insider"},{"id":6667296,"accession":"0001171843-22-005905","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-22-005905","line_url":"/filing/0001171843-22-005905#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.83,"price_display":"2.83","price_state":"stated","total_value":42450.0,"total_display":"42,450.00","total_whole":"42,450","shares_owned_after":5391873.0,"shares_owned_after_display":"5,391,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-01","scope":"insider"},{"id":6604974,"accession":"0001171843-22-005700","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-22-005700","line_url":"/filing/0001171843-22-005700#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":3.05,"price_display":"3.05","price_state":"stated","total_value":45750.0,"total_display":"45,750.00","total_whole":"45,750","shares_owned_after":5376873.0,"shares_owned_after_display":"5,376,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-17","filed_date":"2022-08-17","scope":"insider"},{"id":6479405,"accession":"0001171843-22-005567","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-22-005567","line_url":"/filing/0001171843-22-005567#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.64,"price_display":"2.64","price_state":"stated","total_value":39600.0,"total_display":"39,600.00","total_whole":"39,600","shares_owned_after":5361873.0,"shares_owned_after_display":"5,361,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-10","filed_date":"2022-08-10","scope":"insider"},{"id":6507041,"accession":"0001171843-22-005231","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-22-005231","line_url":"/filing/0001171843-22-005231#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.58,"price_display":"2.58","price_state":"stated","total_value":38700.0,"total_display":"38,700.00","total_whole":"38,700","shares_owned_after":5346873.0,"shares_owned_after_display":"5,346,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-02","scope":"insider"},{"id":6964673,"accession":"0001171843-22-004440","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-22-004440","line_url":"/filing/0001171843-22-004440#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.8,"price_display":"2.80","price_state":"stated","total_value":56000.0,"total_display":"56,000.00","total_whole":"56,000","shares_owned_after":5331873.0,"shares_owned_after_display":"5,331,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-21","filed_date":"2022-06-21","scope":"insider"},{"id":6540266,"accession":"0001171843-22-004408","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-22-004408","line_url":"/filing/0001171843-22-004408#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.34,"price_display":"2.34","price_state":"stated","total_value":46800.0,"total_display":"46,800.00","total_whole":"46,800","shares_owned_after":5311873.0,"shares_owned_after_display":"5,311,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-16","filed_date":"2022-06-17","scope":"insider"},{"id":6175687,"accession":"0001171843-22-004327","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-22-004327","line_url":"/filing/0001171843-22-004327#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":2.29,"price_display":"2.29","price_state":"stated","total_value":68700.0,"total_display":"68,700.00","total_whole":"68,700","shares_owned_after":5291873.0,"shares_owned_after_display":"5,291,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-13","filed_date":"2022-06-13","scope":"insider"},{"id":6748705,"accession":"0001171843-22-004190","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-22-004190","line_url":"/filing/0001171843-22-004190#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":2.83,"price_display":"2.83","price_state":"stated","total_value":84900.0,"total_display":"84,900.00","total_whole":"84,900","shares_owned_after":5261873.0,"shares_owned_after_display":"5,261,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2022-06-07","scope":"insider"},{"id":6201693,"accession":"0001171843-22-004068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-22-004068","line_url":"/filing/0001171843-22-004068#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":3.03,"price_display":"3.03","price_state":"stated","total_value":60600.0,"total_display":"60,600.00","total_whole":"60,600","shares_owned_after":5231873.0,"shares_owned_after_display":"5,231,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-01","scope":"insider"},{"id":6916092,"accession":"0001171843-22-003978","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-22-003978","line_url":"/filing/0001171843-22-003978#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":3.04,"price_display":"3.04","price_state":"stated","total_value":60800.0,"total_display":"60,800.00","total_whole":"60,800","shares_owned_after":5211873.0,"shares_owned_after_display":"5,211,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-26","filed_date":"2022-05-26","scope":"insider"},{"id":6774924,"accession":"0001171843-22-003899","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-22-003899","line_url":"/filing/0001171843-22-003899#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18355.0,"shares_display":"18,355","price_per_share":2.72,"price_display":"2.72","price_state":"stated","total_value":49925.6,"total_display":"49,925.60","total_whole":"49,926","shares_owned_after":5191873.0,"shares_owned_after_display":"5,191,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-05-24","scope":"insider"},{"id":6241313,"accession":"0001171843-22-003771","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-22-003771","line_url":"/filing/0001171843-22-003771#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20215.0,"shares_display":"20,215","price_per_share":2.47,"price_display":"2.47","price_state":"stated","total_value":49931.05,"total_display":"49,931.05","total_whole":"49,931","shares_owned_after":5173518.0,"shares_owned_after_display":"5,173,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-17","filed_date":"2022-05-17","scope":"insider"},{"id":6141569,"accession":"0001171843-22-003503","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001171843-22-003503","line_url":"/filing/0001171843-22-003503#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"CMPX","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27836.0,"shares_display":"27,836","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":50104.8,"total_display":"50,104.80","total_whole":"50,105","shares_owned_after":5153303.0,"shares_owned_after_display":"5,153,303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-10","filed_date":"2022-05-10","scope":"insider"},{"id":2841011,"accession":"0001213900-20-015638","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-20-015638","line_url":"/filing/0001213900-20-015638#line-1","is_derivative":false,"issuer_cik":"0001591464","issuer_name":"Compass Therapeutics, Inc.","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001591464","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":97431.0,"shares_display":"97,431","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":487155.0,"total_display":"487,155.00","total_whole":"487,155","shares_owned_after":4525467.0,"shares_owned_after_display":"4,525,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-19","filed_date":"2020-06-23","scope":"insider"},{"id":3282448,"accession":"0001140361-16-058107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-058107","line_url":"/filing/0001140361-16-058107#line-1","is_derivative":false,"issuer_cik":"0001416792","issuer_name":"Relypsa Inc","issuer_ticker":"RLYP","issuer_name_source":null,"issuer_url":"/issuer/0001416792","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":13.3944,"price_display":"13.39","price_state":"stated","total_value":401832.0,"total_display":"401,832.00","total_whole":"401,832","shares_owned_after":33962.0,"shares_owned_after_display":"33,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-15","filed_date":"2016-03-16","scope":"insider"},{"id":8325756,"accession":"0001140361-15-024342","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-024342","line_url":"/filing/0001140361-15-024342#line-1","is_derivative":false,"issuer_cik":"0001416792","issuer_name":"Relypsa Inc","issuer_ticker":"RLYP","issuer_name_source":null,"issuer_url":"/issuer/0001416792","owner_cik":"0001591464","owner_name":"Schuetz Thomas J.","owner_display_name":"Schuetz Thomas J.","owner_url":"/insider/0001591464","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":34.571,"price_display":"34.57","price_state":"stated","total_value":34571.0,"total_display":"34,571.00","total_whole":"34,571","shares_owned_after":3962.0,"shares_owned_after_display":"3,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-11","filed_date":"2015-06-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":24,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001738021","name":"Compass Therapeutics, Inc.","url":"/issuer/0001738021","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","n_filings":23,"first_seen":"2020-06-23","last_seen":"2025-05-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001416792","name":"Relypsa Inc","url":"/issuer/0001416792","role":"Director","n_filings":2,"first_seen":"2015-06-15","last_seen":"2016-03-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001591464","retrieved_at":"2026-08-26T15:38:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}